Subscribe to RSS
DOI: 10.1055/s-2001-15252
Possibilities and Limitations of Automated Platelet Counting Procedures in the Thrombocytopenic Range
Publication History
Publication Date:
31 December 2001 (online)
![](https://www.thieme-connect.de/media/sth/200103/lookinside/thumbnails/10.1055-s-2001-15252-1.jpg)
ABSTRACT
The clinical decision to proceed with prophylactic platelet transfusions is widely based on trigger points for platelet counts being equal to 20, 10, or even 5 × 10
@affil9:9/L. But an increasing number of publications show evidence that the conventional automated platelet counting methods are unable to provide consistently accurate results in this lower thrombocytopenic range. These measurement errors are mainly associated with the most commonly used impedance principle; optical methods seem to be more precise. The problems of counting imprecision in the low thrombocytopenic range can be avoided with direct or indirect immunological counting methods using monoclonal antibodies or by time-consuming manual procedures. But how should new counting procedures be evaluated? Which method should be used as the ``gold standard'' for platelet counting? A way out of this apparent dilemma is the application of a statistical procedure as proposed by Gautschi et al. This mathematical model allows a reference method independent evaluation of new methods by calculation of the limits of detection (LD) and limits of quantification (LQ) based on the imprecision profile of the investigated method. Using this evaluation procedure, it can be shown that immunological automated counting methods can provide reliable, sufficient, and prompt platelet counts, especially in the thrombocytopenic range.
KEYWORD
Platelet counting - thrombocytopenia - interferences - CD61 - flow cytometry
REFERENCES
- 1 Slichter S J, Harker L A. Thrombocytopenia: mechanisms and management. Clin Haematol . 1978; 7 523-539
- 2 Beutler E. Platelet transfusion: the 20,000/μl trigger. Blood . 1993; 81 1411-1413
- 3 Sutor A H. Acute immune thrombocytopenia in childhood. Are we treating the platelet count?. Semin Thromb Hemost 24;. 1998; 545-548
- 4 Pisciotto P T, Benson K, Hume H. Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients. Transfusion . 1995; 35 498-502
- 5 Wallace E L, Churchill W H, Surgenor D M. Collection and transfusion of blood and blood components in the United States, 1992. Transfusion . 1995; 35 802-812
- 6 Gaydos L A, Freireich E J, Mantel N. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia. N Engl J Med . 1962; 266 905-912
- 7 Gil-Fernandez J J, Alegre A, Fernandez-Villalta M J. Clinical results of a stringent policy on prophylactic platelet transfusion: non-randomized comparative analysis in 190 bone marrow transplant patients from a single institution. Bone Marrow Transplant . 1996; 18 931-935
- 8 Heckman, K D, Weiner G J, Davis C S, et al.. Randomized study of prophylactic platelet transfusion threshold during induction therapy for adult acute leukemia: 10,000/microL versus 20,000/microL. J Clin Oncol . 1997; 15 1143-1149
- 9 Rebulla P, Finazzi G, Marangoni F. A multicenter randomized study of the threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N Engl J Med . 1997; 337 1870-1874
- 10 Want H, Frank M, Ehninger G. Safety and cost effectiveness of a 10 × 109/l trigger for prophylactic platelet transfusions compared with the traditional 20 × 109/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia. Blood . 1998; 91 3601-3606
- 11 Ancliff P J, Machin S J. Trigger factors for prophylactic platelet transfusion. Blood Rev . 1998; 12 234-238
- 12 Bernstein S H, Nademanee A P, Vose J M. A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantation. Blood . 1998; 91 3509-3517
- 13 Rebulla P. Trigger for platelet transfusion. Vox Sang . 2000; 78 179-182
- 14 Gmur J, Burger J, Schanz U, Fehr J, Schaffner A. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukemia. Lancet . 1991; 338 1223-1226
- 15 Decary F, Ferner P, Giavedoni L. An investigation of nonhemolytic transfusion reactions. Vox Sang . 1984; 46 277-285
- 16 Dodd R Y. The risk of transfusion-transmitted infection. N Engl J Med . 1992; 327 419-421
- 17 Slichter S J. Prevention of platelet alloimmunization. In: Murawski K, Peetom F, eds. Transfusion Medicine: Recent Technological Advances New York: Liss 1986: 83-116
- 18 Evans V J, Glasser L. Accuracy of low electronic platelet counts using platelet distribution curves. Am J Med Technol . 1981; 47 15-18
- 19 Koh T, Kabutomori O, Hishiyama M. Discrepancy of platelet numbers between automated blood cell analysis and manual counting in patients with thrombocytopenia. Rinsho Byori . 1996; 44 889-694
- 20 Dickerhoff R, Von Ruecker A. Enumeration of platelets by multiparameter flow cytometry using platelet-specific antibodies and fluorescent reference particles. Clin Lab Haematol . 1995; 17 163-172
- 21 Haung M L, Ho C H. Diagnostic value of an automatic hematology analyzer in patients with hematologic disorders. Adv Ther . 1998; 15 137-141
- 22 Armitage J O, Goeken J A, Feagler J R. Spurious elevation of the platelet count in acute leukemia. JAMA . 1978; 239 433-437
- 23 Malcolm I D, Monks P, Katz M. Spurious thrombocytosis in acute myelocytic leukemia. N Engl J Med . 1977; 298 1260-1264
- 24 Stass S A, Holloway M L, Slease R B, Schumacher H R. Spurious platelet counts in hairy cell leukemia. Am J Clin Pathol . 1977; 68 530-535
- 25 Stass S A, Holloway M L, Peterson V. Cytoplasmic fragments causing spurious platelet counts in the leukemic phase of poorly-differentiated lymphocytic lymphoma. Am J Clin Pathol . 1979; 71 125-131
- 26 Sugimoto T, Saigo K, Ryo R, Yamaguchi N. Giant platelet-like cell fragments produced from abnormal promyelocytes in acute myelogenous leukemia. Rinsho Byori . 1998; 46 182-187
- 27 Hammerstrom H. Spurious platelet counts in acute leukemia with DIC due to cell fragmentation. Clin Lab Haematol . 1992; 14 239-243
- 28 Akwari A M, Ross D W, Stass S A. Spuriously elevated platelet count due to microspherocytosis. Am J Clin Pathol . 1982; 77 220-221
- 29 Cornbleet J. Spurious results from automated cell counters. Lab Med . 1983; 14 509-512
- 30 Paterakis G, Konstantopoulos K, Loukopoulos D. Spuriously increased platelet count due to microcyte interference. Am J Hematol . 1994; 46 46-51
- 31 Sutor A H. Thrombozytenzählung bei Thrombozytopenie. Paediatr Prax . 1995/96; 50 43-52
- 32 Pinkowski R. Difference between impedance and optical platelet counts in patients with microcytosis of red blood cells. Lab Hematol . 1999; 5 22-27
- 33 Morton B D, Orringer E P, LaHart L A, Stass S A. Pappenheimer bodies. An additional cause for a spurious platelet count. Am J Clin Pathol . 1980; 74 310-311
- 34 Howard C A. An atypical spike in a platelet histogram caused by a type I cryoglobulinaemia. Lab Med . 1994; 25 770-773
- 35 Harrison P, Horton A, Grant D, Briggs C, Machin S. Immunoplatelet counting: a proposed new reference procedure. Br J Haematol . 2000; 108 228-235
- 36 Stanworth S J, Denton K, Monteath J, Patton W N. Automated counting of platelets on the Bayer Advia 120 analyzer. Clin Lab Haematol . 1999; 2 113-117
- 37 Rosas-Baruch A, Salas-Montiel R, Loria A, Majluf-Cruz A. External quality control program of four blood cell counters. Rev Invest Clin . 1999; 51 289-292
- 38 Kawai Y, Takeuchi K, Shimizu N. Accuracy, precision and clinically acceptable level of complete blood cell count by an automated multichannel hematology analyzer. Rinsho Byori 47;. 1999; 343-352
- 39 Tanaka C, Ishii T, Fujimoto K. Flow cytometric platelet enumeration in utilizing monoclonal antibody CD42a. Clin Lab Haematol . 1996; 18 265-269
- 40 Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Biochem . 1983; 21 709-720
- 41 Lawrence J B, Yomtovian R A, Dillmann C. Reliability of automated platelet counts; comparison with manual method and utility for prediction of clinical bleeding. Am J Hematol . 1995; 48 244-250
- 42 ICSH (International Council for Standardization in Haematology). Protocol for evaluation of automated blood cell counters. Clin Lab Haematol . 1984; 6 69-84
- 43 ICSH (International Council for Standardization in Haematology). Guidelines for the evaluation of blood cell analysers including those used for differential leukcocyte and reticulocyte counting and cell marker applications. Clin Lab Haematol . 1994; 16 157-174
- 44 Ault K A. Platelet counting: is there room for improvement?. Lab Hematol . 1996; 2 139-143
- 45 Haenseler E, Fehr J, Keller H. Estimation of lower limits of manual and automated platelet counting. Am J Clin Pathol . 1996; 105 782-787
- 46 Gautschi K, Keller B, Keller H, Pei P, Vonderschmitt D J. A new look at the limits of detection (LD), quantification (LQ) and power of definition (PD). Eur J Clin Chem Clin Biochem . 1993; 31 433-440
- 47 Neumüller J, Schwartz D W, Mayr W R. Demonstration by flow cytometry of the numbers of residual white blood cells and platelets in filtered red blood cell concentrates and plasma preparations. Vox Sang . 1997; 73 220-229
- 48 Davis B H, Bigelow N C. Indirect immunoplatelet counting by flow cytometry as a reference method for platelet count calibration. Lab Hematol . 1999; 5 15-21
- 49 Kunz D, Hoeffkes H G, Kunz W S, Gressner A M. A standardized flow cytometric method for the accurate determination of platelet counts in patients with severe thrombocytopenia. Cytometry . 2000; 42 284-289
- 50 Kickler T S, Rothe M, Blosser L, Schisano T, van Hove L. Improving platelet transfusion therapy using the ImmunoPLT method on the Cell-Dyn 4000. Lab Hematol . 1998; 4 80-87
- 51 Kunz D, Kunz W S, Scott S C, Gressner A M. Automated CD61 immunoplatelet analysis of thrombocytopenic samples. Br J Haematol (in press).